Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NID1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | VWC2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | ABHD3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | SSR4 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | ZKSCAN5 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GTPBP8 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | MRPL27 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | FOXN2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | AC027682.1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | SH3KBP1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |